Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
Journal: Cancers
Published: August 09, 2019
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.
Journal: Translational oncology
Published: October 31, 2017
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
Journal: Journal of gastrointestinal oncology
Published: January 13, 2017
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Journal: Ecancermedicalscience
Published: July 15, 2016
Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods.
Journal: Blood cancer journal
Published: July 25, 2015
Oncolytic virotherapy for head and neck cancer: current research and future developments.
Journal: Oncolytic virotherapy
Published: January 01, 2015
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 31, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026